JPWO2021200800A1 - - Google Patents
Info
- Publication number
- JPWO2021200800A1 JPWO2021200800A1 JP2022512195A JP2022512195A JPWO2021200800A1 JP WO2021200800 A1 JPWO2021200800 A1 JP WO2021200800A1 JP 2022512195 A JP2022512195 A JP 2022512195A JP 2022512195 A JP2022512195 A JP 2022512195A JP WO2021200800 A1 JPWO2021200800 A1 JP WO2021200800A1
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/165—Coronaviridae, e.g. avian infectious bronchitis virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Molecular Biology (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Plant Pathology (AREA)
- Pulmonology (AREA)
- Oncology (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020061369 | 2020-03-30 | ||
| PCT/JP2021/013237 WO2021200800A1 (ja) | 2020-03-30 | 2021-03-29 | コロナウイルス感染またはコロナウイルス感染に伴う症状の予防または治療ワクチン |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPWO2021200800A1 true JPWO2021200800A1 (https=) | 2021-10-07 |
Family
ID=77929420
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022512195A Pending JPWO2021200800A1 (https=) | 2020-03-30 | 2021-03-29 |
Country Status (3)
| Country | Link |
|---|---|
| JP (1) | JPWO2021200800A1 (https=) |
| TW (1) | TW202144574A (https=) |
| WO (1) | WO2021200800A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3901261A1 (en) | 2020-04-22 | 2021-10-27 | BioNTech RNA Pharmaceuticals GmbH | Coronavirus vaccine |
| US12186387B2 (en) | 2021-11-29 | 2025-01-07 | BioNTech SE | Coronavirus vaccine |
| JPWO2023145755A1 (https=) | 2022-01-25 | 2023-08-03 | ||
| WO2024002985A1 (en) | 2022-06-26 | 2024-01-04 | BioNTech SE | Coronavirus vaccine |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006009011A1 (ja) * | 2004-07-15 | 2006-01-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | コロナウイルススパイクｓ１融合蛋白及びその発現ベクター |
| JP2006101840A (ja) * | 2004-10-08 | 2006-04-20 | Tokyoto Igaku Kenkyu Kiko | 組み換えウイルスおよびその用途 |
| JP2012510449A (ja) * | 2008-12-02 | 2012-05-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
-
2021
- 2021-03-29 JP JP2022512195A patent/JPWO2021200800A1/ja active Pending
- 2021-03-29 TW TW110111332A patent/TW202144574A/zh unknown
- 2021-03-29 WO PCT/JP2021/013237 patent/WO2021200800A1/ja not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006009011A1 (ja) * | 2004-07-15 | 2006-01-26 | Juridical Foundation The Chemo-Sero-Therapeutic Research Institute | コロナウイルススパイクｓ１融合蛋白及びその発現ベクター |
| JP2006101840A (ja) * | 2004-10-08 | 2006-04-20 | Tokyoto Igaku Kenkyu Kiko | 組み換えウイルスおよびその用途 |
| JP2012510449A (ja) * | 2008-12-02 | 2012-05-10 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | ワクチン |
Non-Patent Citations (1)
| Title |
|---|
| WU F. ET AL.: "Accession No. NC_045512, Definition: Severe acute respiratory syndrome coronavirus 2 isolate Wuhan-H", DATABASE DDBJ/EMBL/GENBANK [ONLINE], JPN6021016798, 13 March 2020 (2020-03-13), ISSN: 0005687759 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2021200800A1 (ja) | 2021-10-07 |
| TW202144574A (zh) | 2021-12-01 |
Similar Documents
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240313 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250422 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250916 |